SCHEMBL20409773

SCHEMBL20409773

CCCc1noc(-c2ccc(N)cc2)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.71
RAB9A P51151 6/20 0.71
ALDH1A1 P00352 5/20 0.71
MAPT P10636 5/20 0.71
SMN1; SMN2 Q16637 4/20 0.71
KDM4E B2RXH2 2/20 0.71
HPGD P15428 2/20 0.71
HSD17B10 Q99714 2/20 0.71
PKM P14618 1/20 0.71
ACHE P22303 2/20 0.57
BCHE P06276 1/20 0.46
NOTUM Q6P988 2/20 0.45
GAA P10253 1/20 0.44
CHRM2 P08172 2/20 0.43
CHRM4 P08173 2/20 0.43
CHRM5 P08912 2/20 0.43
CHRM1 P11229 2/20 0.43
CHRM3 P20309 2/20 0.43
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11338689 0.88 ALDH1A1 (0.56) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL13906032 0.85 NPC1 (0.73) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL10115511 0.83 NPC1 (0.93) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL11968692 0.81 NPC1 (0.69) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL13514083 0.81 NPC1 (0.68) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL12419614 0.80 ALDH1A1 (0.66) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL13064231 0.80 ALDH1A1 (0.66) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL5334470 0.79 ACHE (0.56) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL13906063 0.76 ALDH1A1 (0.61) NPC1RAB9AALDH1A1MAPTSMN1; SMN2
SCHEMBL27001794 0.75 MAPK1 (0.71) NPC1RAB9AALDH1A1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018136202-A2 COMPOUNDS AND METHODS FOR CDK8 MODULATION AND INDICATIONS THEREFOR PLEXXIKON INC. (US) 2018-07-26 WO disclosed